Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
BROMFENAC
(1997)
Small molecule
Unknown
Unknown
Approved
Eye Diseases
BROMFENAC
×
Maximum Phase:
4
First Approval:
1997
UNII:
864P0921DW
Molecule Type:
Small molecule
Molecular Formula:
C15H12BrNO3
Molecular Weight:
334.17
AlogP:
2.89
PSA:
80.39
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TOREMIFENE CITRATE
(1997)
Small molecule
Estrogen receptor modulator
ORAL
Approved
Breast Neoplasms
TOREMIFENE CITRATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
2498Y783QT
Molecule Type:
Small molecule
Molecular Formula:
C32H36ClNO8
Molecular Weight:
598.09
AlogP:
6.22
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
9.0
Source:
SAMARIUM SM 153 LEXIDRONAM PENTASODIUM
(1997)
Small molecule
Unknown
Unknown
Approved
Unknown
SAMARIUM SM 153 LEXIDRONAM PENTASODIUM
×
Maximum Phase:
4
First Approval:
1997
UNII:
7389YR3OOV
Molecule Type:
Small molecule
Molecular Formula:
C6H12N2Na5O12P4Sm
Molecular Weight:
695.93
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DOLASETRON
(1997)
Small molecule
Unknown
Unknown
Approved
Nausea
DOLASETRON
×
Maximum Phase:
4
First Approval:
1997
UNII:
82WI2L7Q6E
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O3
Molecular Weight:
324.38
AlogP:
2.52
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
2.0
Source:
QUETIAPINE
(1997)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
QUETIAPINE
×
Maximum Phase:
4
First Approval:
1997
UNII:
BGL0JSY5SI
Molecule Type:
Small molecule
Molecular Formula:
C21H25N3O2S
Molecular Weight:
383.52
AlogP:
2.86
PSA:
48.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FEPRAZONE
(1997)
Small molecule
Unknown
Unknown
Approved
Arthralgia; Myalgia; Rheumatic Diseases
FEPRAZONE
×
Maximum Phase:
4
First Approval:
1997
UNII:
7BVX6J0CGR
Molecule Type:
Small molecule
Molecular Formula:
C20H20N2O2
Molecular Weight:
320.39
AlogP:
3.95
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
4.0
Source:
NELFINAVIR MESYLATE
(1997)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
HIV Infections
NELFINAVIR MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
98D603VP8V
Molecule Type:
Small molecule
Molecular Formula:
C33H49N3O7S2
Molecular Weight:
663.9
AlogP:
4.75
PSA:
101.9
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ROPINIROLE
(1997)
Small molecule
Unknown
Unknown
Approved
Parkinson Disease
ROPINIROLE
×
Maximum Phase:
4
First Approval:
1997
UNII:
030PYR8953
Molecule Type:
Small molecule
Molecular Formula:
C16H24N2O
Molecular Weight:
260.38
AlogP:
2.85
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ANAGRELIDE
(1997)
Small molecule
Unknown
Unknown
Approved
Neoplasms
ANAGRELIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
K9X45X0051
Molecule Type:
Small molecule
Molecular Formula:
C10H7Cl2N3O
Molecular Weight:
256.09
AlogP:
1.93
PSA:
44.7
HBD:
1.0
HBA:
#RotB:
0.0
Source:
EPROSARTAN MESYLATE
(1997)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Hypertension
EPROSARTAN MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
8N2L1NX8S3
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O7S2
Molecular Weight:
520.63
AlogP:
4.74
PSA:
92.42
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ROPINIROLE HYDROCHLORIDE
(1997)
Small molecule
D2-like dopamine receptor agonist
ORAL
Approved
Parkinson Disease; Restless Legs Syndrome
ROPINIROLE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
D7ZD41RZI9
Molecule Type:
Small molecule
Molecular Formula:
C16H25ClN2O
Molecular Weight:
296.84
AlogP:
2.85
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TAZAROTENE
(1997)
Small molecule
Retinoic acid receptor agonist
Unknown
Approved
Acne Vulgaris; Hypopigmentation; Lentigo; Psoriasis
TAZAROTENE
×
Maximum Phase:
4
First Approval:
1997
UNII:
81BDR9Y8PS
Molecule Type:
Small molecule
Molecular Formula:
C21H21NO2S
Molecular Weight:
351.47
AlogP:
4.43
PSA:
39.19
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TAMSULOSIN
(1997)
Small molecule
Unknown
Unknown
Approved
Prostatic Hyperplasia
TAMSULOSIN
×
Maximum Phase:
4
First Approval:
1997
UNII:
G3P28OML5I
Molecule Type:
Small molecule
Molecular Formula:
C20H28N2O5S
Molecular Weight:
408.52
AlogP:
2.34
PSA:
99.88
HBD:
2.0
HBA:
#RotB:
11.0
Source:
FENOLDOPAM MESYLATE
(1997)
Small molecule
Dopamine D1 receptor agonist
Unknown
Approved
Hypertension
FENOLDOPAM MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
HA3R0MY016
Molecule Type:
Small molecule
Molecular Formula:
C17H20ClNO6S
Molecular Weight:
401.87
AlogP:
2.73
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
1.0
Source:
EPROSARTAN
(1997)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
EPROSARTAN
×
Maximum Phase:
4
First Approval:
1997
UNII:
2KH13Z0S0Y
Molecule Type:
Small molecule
Molecular Formula:
C23H24N2O4S
Molecular Weight:
424.52
AlogP:
4.74
PSA:
92.42
HBD:
2.0
HBA:
#RotB:
10.0
Source:
CLOPIDOGREL
(1997)
Small molecule
Unknown
Unknown
Approved
Thrombosis
CLOPIDOGREL
×
Maximum Phase:
4
First Approval:
1997
UNII:
A74586SNO7
Molecule Type:
Small molecule
Molecular Formula:
C16H16ClNO2S
Molecular Weight:
321.83
AlogP:
3.67
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TALC
(1997)
Small molecule
Unknown
INTRAPLEURAL
Approved
Pleural Effusion
TALC
×
Maximum Phase:
4
First Approval:
1997
UNII:
7SEV7J4R1U
Molecule Type:
Small molecule
Molecular Formula:
Mg3O11Si4
Molecular Weight:
361.25
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ALATROFLOXACIN
(1997)
Small molecule
Unknown
Unknown
Approved
Unknown
ALATROFLOXACIN
×
Maximum Phase:
4
First Approval:
1997
UNII:
7QVV6I50DT
Molecule Type:
Small molecule
Molecular Formula:
C26H25F3N6O5
Molecular Weight:
558.52
AlogP:
0.9
PSA:
159.65
HBD:
4.0
HBA:
#RotB:
7.0
Source:
MODAFINIL
(1998)
Small molecule
Dopamine transporter inhibitor
ORAL
Approved
Attention Deficit Disorder with Hyperactivity
MODAFINIL
×
Maximum Phase:
4
First Approval:
1998
UNII:
R3UK8X3U3D
Molecule Type:
Small molecule
Molecular Formula:
C15H15NO2S
Molecular Weight:
273.36
AlogP:
2.01
PSA:
60.16
HBD:
1.0
HBA:
#RotB:
5.0
Source:
NARATRIPTAN
(1998)
Small molecule
Unknown
Unknown
Approved
Migraine Disorders
NARATRIPTAN
×
Maximum Phase:
4
First Approval:
1998
UNII:
QX3KXL1ZA2
Molecule Type:
Small molecule
Molecular Formula:
C17H25N3O2S
Molecular Weight:
335.47
AlogP:
2.07
PSA:
65.2
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MONTELUKAST SODIUM
(1998)
Small molecule
Cysteinyl leukotriene receptor 1 antagonist
ORAL
Approved
Asthma; Asthma, Exercise-Induced; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
MONTELUKAST SODIUM
×
Maximum Phase:
4
First Approval:
1998
UNII:
U1O3J18SFL
Molecule Type:
Small molecule
Molecular Formula:
C35H35ClNNaO3S
Molecular Weight:
608.18
AlogP:
8.95
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
12.0
Source:
ABACAVIR SULFATE
(1998)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
Autoimmune Diseases; HIV Infections
ABACAVIR SULFATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
1PPL256S5A
Molecule Type:
Small molecule
Molecular Formula:
C28H38N12O6S
Molecular Weight:
670.76
AlogP:
1.09
PSA:
101.88
HBD:
3.0
HBA:
#RotB:
4.0
Source:
RIZATRIPTAN BENZOATE
(1998)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
RIZATRIPTAN BENZOATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
WR978S7QHH
Molecule Type:
Small molecule
Molecular Formula:
C22H25N5O2
Molecular Weight:
391.48
AlogP:
1.91
PSA:
49.74
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CITALOPRAM HYDROBROMIDE
(1998)
Small molecule
Serotonin transporter inhibitor
Unknown
Approved
Depressive Disorder; Depressive Disorder, Major
CITALOPRAM HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
I1E9D14F36
Molecule Type:
Small molecule
Molecular Formula:
C20H22BrFN2O
Molecular Weight:
405.31
AlogP:
3.81
PSA:
36.26
HBD:
0.0
HBA:
#RotB:
5.0
Source:
MONTELUKAST
(1998)
Small molecule
Unknown
Unknown
Approved
Asthma; Asthma, Exercise-Induced; Lung Diseases, Obstructive; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal
MONTELUKAST
×
Maximum Phase:
4
First Approval:
1998
UNII:
MHM278SD3E
Molecule Type:
Small molecule
Molecular Formula:
C35H36ClNO3S
Molecular Weight:
586.2
AlogP:
8.95
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
12.0
Source:
EFAVIRENZ
(1998)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
Autoimmune Diseases; HIV Infections; Infections; Virus Diseases
EFAVIRENZ
×
Maximum Phase:
4
First Approval:
1998
UNII:
JE6H2O27P8
Molecule Type:
Small molecule
Molecular Formula:
C14H9ClF3NO2
Molecular Weight:
315.68
AlogP:
4.07
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CAPECITABINE
(1998)
Small molecule
DNA inhibitor
ORAL
Approved
Breast Neoplasms; Colonic Neoplasms; Neoplasms
CAPECITABINE
×
Maximum Phase:
4
First Approval:
1998
UNII:
6804DJ8Z9U
Molecule Type:
Small molecule
Molecular Formula:
C15H22FN3O6
Molecular Weight:
359.35
AlogP:
0.76
PSA:
122.91
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TIROFIBAN HYDROCHLORIDE
(1998)
Small molecule
Integrin alpha-IIb/beta-3 inhibitor
INJECTION
Approved
Myocardial Infarction
TIROFIBAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
6H925F8O5J
Molecule Type:
Small molecule
Molecular Formula:
C22H39ClN2O6S
Molecular Weight:
495.08
AlogP:
2.95
PSA:
104.73
HBD:
3.0
HBA:
#RotB:
14.0
Source:
BRINZOLAMIDE
(1998)
Small molecule
Carbonic anhydrase II inhibitor
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
BRINZOLAMIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
9451Z89515
Molecule Type:
Small molecule
Molecular Formula:
C12H21N3O5S3
Molecular Weight:
383.52
AlogP:
0.09
PSA:
118.8
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
(1998)
Small molecule
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
INJECTION
Approved
Unknown
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
UXH81S8ZVB
Molecule Type:
Small molecule
Molecular Formula:
C23H32ClNO7
Molecular Weight:
469.96
AlogP:
2.52
PSA:
94.53
HBD:
1.0
HBA:
#RotB:
9.0
Source:
RISEDRONATE SODIUM
(1998)
Small molecule
Farnesyl diphosphate synthase inhibitor
ORAL
Approved
Osteitis Deformans; Osteoporosis; Osteoporosis, Postmenopausal
RISEDRONATE SODIUM
×
Maximum Phase:
4
First Approval:
1998
UNII:
OFG5EXG60L
Molecule Type:
Small molecule
Molecular Formula:
C7H10NNaO7P2
Molecular Weight:
305.1
AlogP:
-0.37
PSA:
148.18
HBD:
5.0
HBA:
#RotB:
4.0
Source:
VALRUBICIN
(1998)
Small molecule
DNA inhibitor
INTRAVESICAL
Approved
Carcinoma; Neoplasms
VALRUBICIN
×
Maximum Phase:
4
First Approval:
1998
UNII:
2C6NUM6878
Molecule Type:
Small molecule
Molecular Formula:
C34H36F3NO13
Molecular Weight:
723.65
AlogP:
2.46
PSA:
215.22
HBD:
5.0
HBA:
#RotB:
10.0
Source:
SILDENAFIL
(1998)
Small molecule
Unknown
Unknown
Approved
Erectile Dysfunction
SILDENAFIL
×
Maximum Phase:
4
First Approval:
1998
UNII:
3M7OB98Y7H
Molecule Type:
Small molecule
Molecular Formula:
C22H30N6O4S
Molecular Weight:
474.59
AlogP:
1.61
PSA:
113.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
LEFLUNOMIDE
(1998)
Small molecule
Dihydroorotate dehydrogenase inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases; Multiple Sclerosis
LEFLUNOMIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
G162GK9U4W
Molecule Type:
Small molecule
Molecular Formula:
C12H9F3N2O2
Molecular Weight:
270.21
AlogP:
3.25
PSA:
55.13
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SEVELAMER HYDROCHLORIDE
(1998)
Small molecule
Phosphate sequestering agent
ORAL
Approved
Unknown
SEVELAMER HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
GLS2PGI8QG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOLTERODINE TARTRATE
(1998)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
ORAL
Approved
Urinary Bladder, Overactive; Urinary Incontinence, Urge
TOLTERODINE TARTRATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
5T619TQR3R
Molecule Type:
Small molecule
Molecular Formula:
C26H37NO7
Molecular Weight:
475.58
AlogP:
5.34
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
7.0
Source:
1
2
…
47
48
49
50
51
52
53
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA